Royal Bank of Canada Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $43.00

Acadia Healthcare (NASDAQ:ACHC - Free Report) had its target price reduced by Royal Bank of Canada from $64.00 to $43.00 in a research report report published on Monday morning,Benzinga reports. They currently have an outperform rating on the stock.

A number of other analysts have also weighed in on ACHC. Barclays lowered shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and cut their price objective for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. StockNews.com downgraded Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday, January 6th. Bank of America decreased their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, KeyCorp decreased their price target on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating for the company in a report on Monday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $56.31.

Acadia Healthcare Stock Performance

NASDAQ:ACHC traded up $0.23 during midday trading on Monday, hitting $29.91. The company's stock had a trading volume of 2,802,175 shares, compared to its average volume of 1,845,570. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a fifty-two week low of $28.09 and a fifty-two week high of $85.96. The firm's 50 day moving average is $41.63 and its 200-day moving average is $50.86. The firm has a market cap of $2.78 billion, a P/E ratio of 9.81, a P/E/G ratio of 1.46 and a beta of 1.30.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently bought and sold shares of ACHC. Phocas Financial Corp. lifted its position in shares of Acadia Healthcare by 30.6% during the 4th quarter. Phocas Financial Corp. now owns 94,320 shares of the company's stock valued at $3,740,000 after buying an additional 22,095 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in Acadia Healthcare during the fourth quarter valued at $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Acadia Healthcare by 22.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company's stock valued at $12,439,000 after purchasing an additional 56,647 shares during the period. Voloridge Investment Management LLC purchased a new stake in shares of Acadia Healthcare during the fourth quarter worth about $15,770,000. Finally, Squarepoint Ops LLC purchased a new position in Acadia Healthcare in the 4th quarter valued at about $1,087,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.